"Designing Growth Strategies is in our DNA"

U.S. Joint Pain Injections Market Size, Share & COVID-19 Impact Analysis, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet Rich Plasma Injections, and Others), By Joint Type (Knee, Hip, Hand & Wrist, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Region : USA | Format: PDF | Report ID: FBI108119



Play Audio Listen to Audio Version

The U.S. joint pain injections market size was worth USD 1.96 billion in 2022 and is projected to grow at a CAGR of 8.9% during the forecast period. 

The prevalence of rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders among the U.S. adult population and children is rising. For instance, according to 2020 statistics published by CDC, around 32.5 million U.S. adults suffer from osteoarthritis. The increased awareness of the conditions and improved diagnosis rate in the country supports the market’s growth of joint pain injections and therapies.

Major industry players are actively focused on research and development activities for developing novel therapies in pain management.  According to the 2022 Sanofi annual report, there are around 14 new molecular entities in immunology and inflammation in the pipeline.  Also, the increased efforts of the key players to expand their geographical footprint supports the accessibility of the products in developing countries. The COVID-19 impact on the market was negative due to decreased patient visits to hospitals and clinics to treat joint disorders. The cancellation or postponement of appointments by the patients owing to the fear of contraction of COVID-19 infection hindered the U.S. joint pain injections market growth in 2020.


Increasing Number of Minimally Invasive Procedures for Musculoskeletal Disorders 

The administration of steroid injections is considered a minimally invasive procedure for joint pain. There are several advantages of minimally invasive surgical procedures for joint disorders, such as reduced pain, reduced bleeding, and rapid recovery, among others which lead to an increased preference for minimally invasive surgeries among patients. The adoption of joint pain injections among healthcare providers is due to their clinical advantages, such as drug adsorption and a longer relief period for patients.

Additionally, there are several ongoing clinical trials for various stem cell therapies to treat joint pain, which is currently a trend for joint pain management.


Rising Incidence of Sports Injuries and Awareness Regarding Joint Disorders to Foster the Demand in the Market

There is a growing incidence of sports injuries resulting in frequent muscle tears, joint pain, and fractures, among others. Moreover, the prevalence of musculoskeletal conditions leading to severe joint pain and other issues is also on the rise among the adult population in the U.S. According to a study conducted by the Burden of Musculoskeletal Conditions in the U.S., more than half of the American population over the age of 18 (54.0%) are affected by musculoskeletal (bone and joint) conditions.

The number of sports injuries increased after the COVID-19 pandemic due to lockdown restrictions and reopening of sports clubs, schools, universities, and others.

According to the 2021 article published by the National Safety Council, sports and recreational injuries increased by around 20% in 2021 compared to the previous year. 

Request a Free sample to learn more about this report.


Complications Associated with the Administration of Joint Pain Injections  

The use of joint pain injections for the long term may pose short or long-term complications among the patients, such as intense pain and swelling at the site of injection, stress fractures, and collapse of joints, among others.

According to a report published by the Radiological Society of North America, a recent retrospective observational study by Simeone et. al focused on intra-articular corticosteroid injection in the hip and subsequent joint events in 70 patients. They reported that 17.0% of patients developed articular surface collapse and even more adverse joint pain events.

Also, the high cost of hyaluronic acid injections for osteoarthritis and other joint disorders is expected to hamper the patient’s demand for these injections.


By Product Analysis

Based on product, the market is segmented into corticosteroid injections, hyaluronic acid injections, platelet rich plasma injections, and others.  

The hyaluronic acid injections segment dominated the U.S. joint pain injections market share in 2022. The dominance is attributed to the increasing adoption of visco-supplement injections, owing to favorable reimbursement policies in the U.S. for the treatment of osteoarthritis.

According to CMS, Medicare covers hyaluronic injections for pain management approved by the U.S. FDA and provides coverage to patients for one injection every 6 months.

By Joint Type Analysis

Based on joint type, the market is segmented into knee, hip, hand & wrist, and others.

The knee segment held the largest U.S. market share in 2022 and is expected to grow at a moderate CAGR during the forecast period. The prevalence and risk of knee osteoarthritis among the geriatric population is rising in the country. The growing geriatric population with a higher risk of the condition is expected to foster the segment's growth during the forecast period.

As per a 2022 article published by National Center for Biotechnology & Information, it was reported that the incidence of symptomatic knee osteoarthritis is approximately 240 cases per 100,000 people per year.

By Distribution Channel Analysis

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

The retail pharmacies segment dominated the market in 2022 and is expected to grow at a considerable CAGR during the forecast period. The segment’s growth is attributed to the rising number of retail pharmacies in the country and the growing demand for injections.


The U.S. joint pain injections market is a fragmented market with numerous players in the country.

Some key players of this injections are Bioventus, Anika Therapeutics, Inc., Zimmer Biomet, and Teva Pharmaceutical Industries Ltd. The rising R&D focus of these companies is to develop and introduce novel products for treating various musculoskeletal disorders in the country.

For instance, in November 2022, Anika Therapeutics, Inc. announced that Cingal met its primary endpoint in a Phase III Study, demonstrating superiority over triamcinolone hexacetonide (TH) steroid alone at 26 weeks post-treatment.

Other prominent players of joint pain injections include Ferring B.V., SEIKAGAKU CORPORATION, and Pacira BioSciences, Inc., among others. The robust efforts of these players to penetrate the U.S. market with their product portfolio through mergers and acquisitions is one of the important factors supporting the growing market share of these players.


  • Sanofi (France)


  • Bioventus (U.S.)

  • Anika Therapeutics, Inc. (U.S.)

  • Pacira BioSciences, Inc. (U.S.)

  • Dr. Reddy’s Laboratories Ltd. (India)

  • Zimmer Biomet (U.S.)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Ferring B.V. (Switzerland)


  • April 2022 – Dr. Reddy’s Laboratories Ltd. launched Methylprednisolone Sodium Succinate for Injection, USP. It is a generic equivalent of SOLU-MEDROL in the U.S. for the treatment of blood disorders, arthritis, and other allergic conditions.

  • March 2022 - Anika Therapeutics, Inc. announced that it will showcase its comprehensive joint preservation and restoration product portfolio at the 2022 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting on March 23 - 25 in Chicago, U.S.

  • May 2020 - Teva Pharmaceuticals USA, Inc., and Celltrion Healthcare Co., Ltd., announced that TRUXIMA (rituximab-abbs) injection is now available in the U.S. for the treatment of Rheumatoid Arthritis (RA) in combination with methotrexate in adult patients with moderately-to severely-active rheumatoid arthritis.


The market research report provides a detailed analysis of the market. It focuses on key aspects, including technological advancements, the prevalence of rheumatoid arthritis, musculoskeletal disorders in the U.S., and pricing analysis. Additionally, it includes the latest trends in the market, new product launches, key industry developments, including mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. In addition to the aforementioned factors, it includes several factors that contributed to the growth of the market in recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation



Study Period


Base Year


Estimated Year


Forecast Period


Historical Period


Growth Rate

CAGR of 8.9% from 2023 to 2030


Value (USD Billion)


By Product

  • Corticosteroid Injections

  • Hyaluronic Acid Injections

  • Platelet Rich Plasma Injections

  • Others

By Joint Type

  • Knee

  • Hip

  • Hand & Wrist

  • Others

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth 1.96 billion in 2022.

The market is expected to exhibit a CAGR of 8.9% during the forecast period (2023-2030).

By product, hyaluronic acid injections segment accounts for a considerable proportion of the market.

Bioventus, Anika Therapeutics, Inc., and SEIKAGAKU CORPORATION are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Aug, 2023
  • 2022
  • 2019-2021
  • 92


  • $2850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.